Cargando…

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis

Detalles Bibliográficos
Autores principales: Zan, Jincan, Ma, Jun, Man, Qian, Liu, Xingzi, Yu, Donghe, Zhang, Yuemiao, Lv, Jicheng, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977377/
https://www.ncbi.nlm.nih.gov/pubmed/35399860
http://dx.doi.org/10.1016/j.ekir.2022.03.025
_version_ 1784680752056631296
author Zan, Jincan
Ma, Jun
Man, Qian
Liu, Xingzi
Yu, Donghe
Zhang, Yuemiao
Lv, Jicheng
Zhang, Hong
author_facet Zan, Jincan
Ma, Jun
Man, Qian
Liu, Xingzi
Yu, Donghe
Zhang, Yuemiao
Lv, Jicheng
Zhang, Hong
author_sort Zan, Jincan
collection PubMed
description
format Online
Article
Text
id pubmed-8977377
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89773772022-04-04 Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis Zan, Jincan Ma, Jun Man, Qian Liu, Xingzi Yu, Donghe Zhang, Yuemiao Lv, Jicheng Zhang, Hong Kidney Int Rep Letter to the Editor Elsevier 2022-04-04 /pmc/articles/PMC8977377/ /pubmed/35399860 http://dx.doi.org/10.1016/j.ekir.2022.03.025 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zan, Jincan
Ma, Jun
Man, Qian
Liu, Xingzi
Yu, Donghe
Zhang, Yuemiao
Lv, Jicheng
Zhang, Hong
Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title_full Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title_fullStr Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title_full_unstemmed Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title_short Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
title_sort safety evaluation of covid-19 vaccine in patients with iga nephropathy or iga vasculitis nephritis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977377/
https://www.ncbi.nlm.nih.gov/pubmed/35399860
http://dx.doi.org/10.1016/j.ekir.2022.03.025
work_keys_str_mv AT zanjincan safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT majun safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT manqian safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT liuxingzi safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT yudonghe safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT zhangyuemiao safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT lvjicheng safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis
AT zhanghong safetyevaluationofcovid19vaccineinpatientswithiganephropathyorigavasculitisnephritis